comScore
Active Stocks
Fri Sep 29 2023 15:59:14
  1. Tata Steel share price
  2. 129 1.78%
  1. NTPC share price
  2. 245.65 3.3%
  1. Power Grid Corporation Of India share price
  2. 199.85 -0.45%
  1. State Bank Of India share price
  2. 598.7 1.48%
  1. Wipro share price
  2. 406.25 0.11%
Business News/ News / US FDA lifts clinical hold on Bharat Biotech's Covid vaccine Covaxin
Back

US FDA lifts clinical hold on Bharat Biotech's Covid vaccine Covaxin

Ocugen is co-developing Bharat Biotech's Covaxin vaccine for Covid in the US and Canada

CovaxinPremium
Covaxin

Bharat Biotech's Covaxin will be evaluated as a Covid vaccine candidate in the United States, the company informed on Saturday. 

Ocugen, Inc announced that the US Food and Drug Administration (FDA) has lifted its clinical hld on the company's investigational new drug application to evaluate the Covid vaccine candidate, BB152, known as Covaxin outside the US, Bharat Biotech said in a statement.

Ocugen is co-developing Bharat Biotech's Covaxin vaccine for Covid in US and Canada.

 

 

 

 

 

"Exciting news! Mint is now on WhatsApp Channels 🚀 Subscribe today by clicking the link and stay updated with the latest financial insights!" Click here!

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Updated: 19 Feb 2022, 07:14 PM IST
Next Story
Recommended For You
Switch to the Mint app for fast and personalized news - Get App